Gender transition hormone therapy may increase cardiovascular risk: Study

Updated:3 weeks, 6 days ago IST

New Delhi, Feb 19 (ANI) : A new study revealed that patients receiving hormone therapy as a part of their gender-transition treatment are at an elevated risk of developing cardiovascular diseases, including strokes, heart attacks and blood clots. "In light of our results, we urge both physicians and transgender individuals to be aware of this increased cardiovascular risk," said study author .Past research has shown that hormone therapy increases cardiovascular risk among people receiving it to alleviate symptoms of menopause, yet research evidence remains scarce on the effects of hormone treatment in people undergoing gender transition . Transgender women, who were receiving hormones as part of their transition had more than twice as many strokes as women and nearly twice as many strokes as men.Transgender men, who received hormones, had a more than three-fold elevation in heart-attack risk compared with women .In previous studies it has been shown that triglyceride and insulin levels, for example, have both increased as a result of estrogen therapy and both are known to promote clogging and inflammation of the blood vessels. Additionally, estrogen therapy can render the blood more prone to clotting, which may explain the higher rate of strokes and blood clots observed in transgender women, the authors said.The rise in heart attack risk observed in transgender men receiving testosterone may be explained partly by the hormone's tendency to make the blood stickier.

Related Video

iocl